Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Oncotarget
Jessica GarciaLéa Payen

Abstract

CfDNA samples from colon (mCRC) and non-small cell lung cancers (NSCLC) (CIRCAN cohort) were compared using three platforms: droplet digital PCR (ddPCR, Biorad); BEAMing/OncoBEAM™-RAS-CRC (Sysmex Inostics); next-generation sequencing (NGS, Illumina), utilizing the 56G oncology panel (Swift Biosciences). Tissue biopsy and time matched cfDNA samples were collected at diagnosis in the mCRC cohort and during 1st progression in the NSCLC cohort. Excellent matches between cfDNA/FFPE mutation profiles were observed. Detection thresholds were between 0.5-1% for cfDNA samples examined using ddPCR and NGS, and 0.03% with BEAMing. This high level of sensitivity enabled the detection of KRAS mutations in 5/19 CRC patients with negative FFPE profiles. In the mCRC cohort, comparison of mutation results obtained by testing FFPE to those obtained by testing cfDNA by ddPCR resulted in 47% sensitivity, 77% specificity, 70% positive predictive value (PPV) and 55% negative predictive value (NPV). For BEAMing, we observed 93% sensitivity, 69% specificity, 78% PPV and 90% NPV. Finally, sensitivity of NGS was 73%, specificity was 77%, PPV 79% and NPV 71%. Our study highlights the complementarity of different diagnostic approaches and variability of r...Continue Reading

References

Jul 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Devin DressmanBert Vogelstein
Nov 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Frank DiehlBert Vogelstein
Jan 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephan E BaldusHelmut E Gabbert
May 13, 2011·Nature Reviews. Cancer·Heidi SchwarzenbachKlaus Pantel
Jun 21, 2011·Small GTPases·Adrienne D Cox, Channing J Der
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Feb 21, 2014·Science Translational Medicine·Chetan BettegowdaLuis A Diaz
Jul 6, 2014·International Journal of Oncology·Sandy ChevrierRomain Boidot
Jul 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sébastien CouraudPierre-Jean Souquet
Oct 24, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kenneth S ThressJ Carl Barrett
Dec 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ondrej FialaJindrich Finek
Jun 15, 2016·Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti·R NěmečekO Slabý
Nov 11, 2016·PloS One·Inga Medina DiazFrank Holtrup
Dec 19, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Aaron M ChapmanAmy K Madl
Jan 28, 2017·Stem Cell Research·Daniel J CooperJohn R McCarrey
Feb 6, 2017·Oncotarget·Alexa GoldsteinPaula J Hurley
Feb 9, 2017·Pharmacology & Therapeutics·Nieves Perdigones, Muhammed Murtaza
Feb 13, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nicolas GuibertJulien Mazières
Apr 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J VidalC Montagut
May 10, 2017·Molecular Diagnosis & Therapy·Susana Olmedillas-LópezDamián García-Olmo

❮ Previous
Next ❯

Citations

Jul 25, 2019·International Journal of Cancer. Journal International Du Cancer·Marin StrijkerHanneke W van Laarhoven
Sep 26, 2019·Clinical Chemistry·Ben O'LearyNicholas C Turner
Jul 11, 2020·Cancer Metastasis Reviews·Gábor LakatosGyörgy Bodoky
Sep 23, 2020·International Journal of Molecular Sciences·Melinda SzilágyiBálint Nagy
Oct 18, 2019·Frontiers in Endocrinology·Kaspars MegnisJanis Klovins
Mar 25, 2020·The Journal of Molecular Diagnostics : JMD·Kaat Van CasterenUNKNOWN International Quality Network for Pathology ctDNA Working Group and the European Society of Pathology Foundation Assessors
May 26, 2021·Scientific Reports·Jessica GarciaCristian Ionescu-Zanetti

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
biopsies
biopsy
PCR
flow cytometry

Software Mentioned

QuantStudio
GraphPad
Variant Caller
Therascreen
Fastq
OncoBEAM
GraphPad InStat

Related Concepts

Related Feeds

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.